Table 2 Schedule of enrolment, interventions, and assessments for patients in the DIALOG+ study (all sites)
Timepoint | Study period | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Enrolment | Allocation | Post-allocation | Close out | ||||||||
-t 1 | Month 0 | t 1 Month 0 | t 2 Month 1 | t 3 Month 2 | t 4 Month 3 | t 5 Month 4 | t 6 Month 5 | t 7 Month 6 | Flexible period Month 7–12 | Month 12 | |
ENROLMENT: | |||||||||||
Eligibility screen | X | ||||||||||
Informed consent | X | ||||||||||
MANSA Screening | X | ||||||||||
Allocation | X | ||||||||||
INTERVENTIONS: | |||||||||||
DIALOG+ | X | X | X | X | X | X | X | X | |||
DIALOG Scale – only in Uganda | X | X | X | X | X | X | X | X | |||
Treatment as Usual – Bosnia and Herzegovina and Colombia | X | X | X | X | X | X | X | X | |||
ASSESSMENTS: | |||||||||||
Socio-demographic Questionnaire | X | ||||||||||
MANSA, BPRS, SIX, CSRI, Additional measures (vary by site) | X | X | X | ||||||||
Adherence Measures | X | X | X | X | X | X | X | X | |||